139 related articles for article (PubMed ID: 25004707)
1. Adopting evidence-based medically assisted treatments in substance abuse treatment organizations: roles of leadership socialization and funding streams.
Blum TC; Davis CD; Roman PM
J Health Hum Serv Adm; 2014; 37(1):37-75. PubMed ID: 25004707
[TBL] [Abstract][Full Text] [Related]
2. Insights from a national survey into why substance abuse treatment units add prevention and outreach services.
Wells R; Lemak CH; D'Aunno TA
Subst Abuse Treat Prev Policy; 2006 Aug; 1():21. PubMed ID: 16887037
[TBL] [Abstract][Full Text] [Related]
3. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure.
Knudsen HK; Abraham AJ; Oser CB
Eval Program Plann; 2011 Nov; 34(4):375-81. PubMed ID: 21371752
[TBL] [Abstract][Full Text] [Related]
4. Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers.
Oser CB; Roman PM
J Stud Alcohol Drugs; 2007 Nov; 68(6):852-61. PubMed ID: 17960303
[TBL] [Abstract][Full Text] [Related]
5. Health services for women in outpatient substance abuse treatment.
Campbell CI; Alexander JA
Health Serv Res; 2005 Jun; 40(3):781-810. PubMed ID: 15960691
[TBL] [Abstract][Full Text] [Related]
6. Science-based and practice-based innovativeness and performance of substance abuse treatment facilities.
Nayar P; Yu F; Apenteng B
Health Care Manage Rev; 2014; 39(1):66-74. PubMed ID: 23358133
[TBL] [Abstract][Full Text] [Related]
7. Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment.
Paino M; Aletraris L; Roman PM
Subst Abus; 2015; 36(4):462-9. PubMed ID: 25257691
[TBL] [Abstract][Full Text] [Related]
8. Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.
Knudsen HK; Abraham AJ
Psychiatr Serv; 2012 Jan; 63(1):19-25. PubMed ID: 22227755
[TBL] [Abstract][Full Text] [Related]
9. The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.
Knudsen HK; Roman PM
J Stud Alcohol Drugs; 2014 May; 75(3):476-85. PubMed ID: 24766760
[TBL] [Abstract][Full Text] [Related]
10. Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.
Abraham AJ; Knudsen HK; Rieckmann T; Roman PM
J Stud Alcohol Drugs; 2013 Mar; 74(2):258-65. PubMed ID: 23384373
[TBL] [Abstract][Full Text] [Related]
11. Organizational characteristics that foster early adoption of cultural and linguistic competence in outpatient substance abuse treatment in the United States.
Guerrero E
Eval Program Plann; 2012 Feb; 35(1):9-15. PubMed ID: 21949458
[TBL] [Abstract][Full Text] [Related]
12. Adoption and implementation of new technologies in substance abuse treatment.
Roman PM; Johnson JA
J Subst Abuse Treat; 2002 Jun; 22(4):211-8. PubMed ID: 12072165
[TBL] [Abstract][Full Text] [Related]
13. Adoption of medications in substance abuse treatment: priorities and strategies of single state authorities.
Rieckmann T; Kovas AE; Rutkowski BA
J Psychoactive Drugs; 2010 Sep; Suppl 6():227-38. PubMed ID: 21138199
[TBL] [Abstract][Full Text] [Related]
14. The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment.
Knudsen HK; Ducharme LJ; Roman PM
J Health Soc Behav; 2007 Jun; 48(2):195-210. PubMed ID: 17583274
[TBL] [Abstract][Full Text] [Related]
15. Exploring Diversification as A Management Strategy in Substance Use Disorder Treatment Organizations.
Fields D; Riesenmy K; Roman PM
J Subst Abuse Treat; 2015 Oct; 57():63-9. PubMed ID: 26021404
[TBL] [Abstract][Full Text] [Related]
16. Patterns of organization and management in private and public substance abuse treatment programs.
Roman PM; Ducharme LJ; Knudsen HK
J Subst Abuse Treat; 2006 Oct; 31(3):235-43. PubMed ID: 16996386
[TBL] [Abstract][Full Text] [Related]
17. Organizational and client determinants of cost in outpatient substance abuse treatment.
Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
[TBL] [Abstract][Full Text] [Related]
18. Organizational implementation of evidence-based substance abuse treatment in racial and ethnic minority communities.
Guerrero EG; He A; Kim A; Aarons GA
Adm Policy Ment Health; 2014 Nov; 41(6):737-49. PubMed ID: 24046236
[TBL] [Abstract][Full Text] [Related]
19. Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations.
Knudsen HK; Roman PM
J Subst Abuse Treat; 2015 Feb; 49():1-7. PubMed ID: 25218918
[TBL] [Abstract][Full Text] [Related]
20. Implementation of evidence-based practices for treatment of alcohol and drug disorders: the role of the state authority.
Rieckmann TR; Kovas AE; Fussell HE; Stettler NM
J Behav Health Serv Res; 2009 Oct; 36(4):407-19. PubMed ID: 18543111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
